Douglas Scott Wieland
Plus aucun poste en cours
Profil
Douglas Scott Wieland worked as a Director of Regulatory Affairs at CoCensys, Inc. from 1990 to 1997.
He then worked as a Senior Vice President of Drug Development at LadRx Corp.
from 2005 to 2017.
He also held positions as Vice President of Product Development at Spectrum Pharmaceuticals, Inc., Vice President of Global Drug Development at PRA Health Sciences, Inc., Vice President of Clinical & Regulatory Affairs at BrainCells, Inc., and Executive Vice President of Development at Nanobiotix SA. Wieland received a graduate and doctorate degree from the University of Arizona, an undergraduate degree from the University of California, Santa Barbara, and an MBA from Webster University.
Anciens postes connus de Douglas Scott Wieland
| Sociétés | Poste | Fin |
|---|---|---|
| PRA HEALTH SCIENCES, INC. | Corporate Officer/Principal | 01/04/2020 |
| LADRX CORPORATION | Corporate Officer/Principal | 13/06/2017 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | General Counsel | 01/01/1997 |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
| NANOBIOTIX | Corporate Officer/Principal | - |
Formation de Douglas Scott Wieland
| University of Arizona | Doctorate Degree |
| University of California, Santa Barbara | Undergraduate Degree |
| Webster University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| LADRX CORPORATION | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| NANOBIOTIX | Health Technology |
| Entreprise privées | 3 |
|---|---|
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | Health Technology |
PRA Health Sciences, Inc.
 PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights, and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC. | Commercial Services |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
